ArticleJournal of nanobiotechnology2023

Injectable hydrogel loaded with lysed OK-432 and doxorubicin for residual liver cancer after incomplete radiofrequency ablation.

Yanyan Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.